Vaxcyte, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
PCVX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
825 Industrial Road, Ste. 300, San Carlos, CA

Insiders trading volume in the past year

Vaxcyte, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jeff Fairman VP, Research $22.9M Dec 30, 2022
Grant Pickering CHIEF EXECUTIVE OFFICER, Director $14.1M -$16.8M -54.3% Apr 4, 2025
Jim Wassil Chief Operating Officer $11.1M -$7.6M -40.5% Feb 27, 2025
Mikhail Eydelman Svp, Gen Counsel & Corp Sec $3.01M -$4.06M -57.4% Mar 5, 2025
Andrew Guggenhime President And Cfo $2.95M -$11M -78.8% Apr 7, 2025
Elvia Cowan Svp, Finance $1.74M -$1.36M -44% Feb 27, 2025
Harpreet S. Dhaliwal SVP Cml Mfg & Supply Chain $1.41M Dec 30, 2022
Peter Hirth Director $1.04M Jun 6, 2024
Paul Sauer SVP Process Dev, Manufacturing $895K Dec 30, 2022
Carlos V. Paya Director $672K Dec 6, 2024
Teri Loxam Director $635K -$1.26M -66.5% Jan 15, 2025
Halley E. Gilbert Director $524K -$1.33M -71.7% Jun 6, 2024
Anne S. Drapeau Director $524K Jun 6, 2024
Michael E. Kamarck Director $364K Jun 13, 2023
Heath Lukatch Director $305K Apr 8, 2025
Jane Wright-Mitchell General Counsel $202K Aug 16, 2021
Jacks Lee Director $113K Jun 6, 2024
Kurt Von Emster Director Jun 2, 2021
Patrick J. Heron Director Jun 2, 2021
John Furey Director Jul 2, 2024
Robert Lorne Hopfner Director Jun 2, 2021

Recent Insider Transactions by Companies or Individuals for Vaxcyte, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.